Apoptosis Antagonizing Transcription Factor (AATF) Peptid
AATF
Reaktivität: Human, Affe
Wirt: Synthetic
BP
-
- Target Alle AATF Produkte
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Spezies
- Human, Affe
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-AATF Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- AATF (Apoptosis Antagonizing Transcription Factor (AATF))
- Synonyme
- AATF Peptide, ded Peptide, che1 Peptide, che-1 Peptide, cb109 Peptide, sb:cb109 Peptide, wu:fc13d05 Peptide, zgc:162071 Peptide, CHE-1 Peptide, CHE1 Peptide, DED Peptide, 4933415H02Rik Peptide, 5830465M17Rik Peptide, Che-1 Peptide, Trb Peptide, Ded Peptide, apoptosis antagonizing transcription factor Peptide, Apoptosis antagonizing transcription factor Peptide, apoptosis antagonizing transcription factor S homeolog Peptide, AATF Peptide, aatf Peptide, BFR2 Peptide, NAEGRDRAFT_56916 Peptide, Aatf Peptide, aatf.S Peptide
- Hintergrund
- CHE1, DED, Protein AATF, Apoptosis-antagonizing transcription factor, Rb-binding protein Che-1
- Gen-ID
- 26574
- UniProt
- Q9NY61
-
Sie sind hier:
